← FDA DRUG APPROVALS

FDA NDA · NDA018962

MANGANESE

manganese chloride

Sponsor: HOSPIRA

APPLICATION
NDA018962
TYPE
NDA
ORIGINAL APPROVAL
1986-06-26
LATEST ACTION
2023-12-18
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

MANGANESE CHLORIDE IN PLASTIC CONTAINER · ReferencePrescription
MANGANESE CHLORIDE EQ 0.1MG MANGANESE/ML · INJECTABLE · INJECTION

Approval history

2023-12-18Labeling · Supplement 30 · standard — Letter ↗AP
2014-06-12Manufacturing (CMC) · Supplement 23 · priorityAP
2004-02-27Labeling · Supplement 7 · standard — Letter ↗AP
2002-12-06Labeling · Supplement 11 · standard — Letter ↗AP
2001-02-16Manufacturing (CMC) · Supplement 10 · priorityAP
1999-08-31Manufacturing (CMC) · Supplement 9 · priorityAP
1999-01-22Manufacturing (CMC) · Supplement 8 · priorityAP
1997-01-17Manufacturing (CMC) · Supplement 5 · priorityAP
1996-08-29Manufacturing (CMC) · Supplement 6 · priorityAP
1987-06-29Manufacturing (CMC) · Supplement 3 · priorityAP
1986-09-09Manufacturing (CMC) · Supplement 1 · priorityAP
1986-06-26Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →